432 related articles for article (PubMed ID: 9767427)
21. Mutants of the Escherichia coli heat-labile enterotoxin with reduced ADP-ribosylation activity or no activity retain the immunogenic properties of the native holotoxin.
de Haan L; Verweij WR; Feil IK; Lijnema TH; Hol WG; Agsteribbe E; Wilschut J
Infect Immun; 1996 Dec; 64(12):5413-6. PubMed ID: 8945598
[TBL] [Abstract][Full Text] [Related]
22. Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection.
Weltzin R; Guy B; Thomas WD; Giannasca PJ; Monath TP
Infect Immun; 2000 May; 68(5):2775-82. PubMed ID: 10768972
[TBL] [Abstract][Full Text] [Related]
23. Safety and immunogenicity of bacterial and tobacco plant cell line derived recombinant native and mutant Escherichia coli heat-labile toxin in chickens.
Miller T; Fanton M; Nickelson S; Mason H; Webb S
Avian Pathol; 2012 Oct; 41(5):441-9. PubMed ID: 22928883
[TBL] [Abstract][Full Text] [Related]
24. Mucosal and systemic antibody responses after peroral or intranasal immunization: effects of conjugation to enterotoxin B subunits and/or of co-administration with free toxin as adjuvant.
Rask C; Fredriksson M; Lindblad M; Czerkinsky C; Holmgren J
APMIS; 2000 Mar; 108(3):178-86. PubMed ID: 10752686
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant effect of non-toxic mutants of E. coli heat-labile enterotoxin following intranasal, oral and intravaginal immunization.
De Magistris MT; Pizza M; Douce G; Ghiara P; Dougan G; Rappuoli R
Dev Biol Stand; 1998; 92():123-6. PubMed ID: 9554265
[TBL] [Abstract][Full Text] [Related]
26. Quantitative Proteomic Analysis of Escherichia coli Heat-Labile Toxin B Subunit (LTB) with Enterovirus 71 (EV71) Subunit VP1.
Liu L; Ma Y; Zhou H; Wu M
Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27618897
[TBL] [Abstract][Full Text] [Related]
27. Novel modifications to the C-terminus of LTB that facilitate site-directed chemical coupling of antigens and the development of LTB as a carrier for mucosal vaccines.
O'Dowd AM; Botting CH; Precious B; Shawcross R; Randall RE
Vaccine; 1999 Mar; 17(11-12):1442-53. PubMed ID: 10195780
[TBL] [Abstract][Full Text] [Related]
28. Escherichia coli heat-labile enterotoxin B subunits supplemented with a trace amount of the holotoxin as an adjuvant for nasal influenza vaccine.
Tamura S; Asanuma H; Tomita T; Komase K; Kawahara K; Danbara H; Hattori N; Watanabe K; Suzuki Y; Nagamine T
Vaccine; 1994 Sep; 12(12):1083-9. PubMed ID: 7998417
[TBL] [Abstract][Full Text] [Related]
29. Comparative analysis of the mucosal adjuvanticity of the type II heat-labile enterotoxins LT-IIa and LT-IIb.
Martin M; Metzger DJ; Michalek SM; Connell TD; Russell MW
Infect Immun; 2000 Jan; 68(1):281-7. PubMed ID: 10603399
[TBL] [Abstract][Full Text] [Related]
30. The role of cAMP in mucosal adjuvanticity of Escherichia coli heat-labile enterotoxin (LT).
Cheng E; Cárdenas-Freytag L; Clements JD
Vaccine; 1999 Aug; 18(1-2):38-49. PubMed ID: 10501233
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the reactogenicity, adjuvanticity and antigenicity of LT(R192G) and LT(R192G/L211A) by intradermal immunization in mice.
Maciel M; Smith M; Poole ST; Laird RM; Rollenhagen JE; Kaminski RW; Wenzel H; Bourgeois AL; Savarino SJ
PLoS One; 2019; 14(11):e0224073. PubMed ID: 31682624
[TBL] [Abstract][Full Text] [Related]
32. Immunoactive chimeric ST-LT enterotoxins of Escherichia coli generated by in vitro gene fusion.
Sanchez J; Uhlin BE; Grundström T; Holmgren J; Hirst TR
FEBS Lett; 1986 Nov; 208(2):194-8. PubMed ID: 2430831
[TBL] [Abstract][Full Text] [Related]
33. Expression of the B subunit of the heat-labile enterotoxin of Escherichia coli in tobacco mosaic virus-infected Nicotiana benthamiana plants and its characterization as mucosal immunogen and adjuvant.
Wagner B; Hufnagl K; Radauer C; Wagner S; Baier K; Scheiner O; Wiedermann U; Breiteneder H
J Immunol Methods; 2004 Apr; 287(1-2):203-15. PubMed ID: 15099768
[TBL] [Abstract][Full Text] [Related]
34. Differential biological and adjuvant activities of cholera toxin and Escherichia coli heat-labile enterotoxin hybrids.
Bowman CC; Clements JD
Infect Immun; 2001 Mar; 69(3):1528-35. PubMed ID: 11179323
[TBL] [Abstract][Full Text] [Related]
35. Mutants of Escherichia coli heat-labile enterotoxin as an adjuvant for nasal influenza vaccine.
Komase K; Tamura S; Matsuo K; Watanabe K; Hattori N; Odaka A; Suzuki Y; Kurata T; Aizawa C
Vaccine; 1998; 16(2-3):248-54. PubMed ID: 9607038
[TBL] [Abstract][Full Text] [Related]
36. Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activity.
Giuliani MM; Del Giudice G; Giannelli V; Dougan G; Douce G; Rappuoli R; Pizza M
J Exp Med; 1998 Apr; 187(7):1123-32. PubMed ID: 9529328
[TBL] [Abstract][Full Text] [Related]
37. Analysis and application of a neutralizing linear epitope on liable toxin B of enterotoxin Escherichia coli.
Guan W; Liu W; Bao J; Li J; Yuan C; Tang J; Shi D
Appl Microbiol Biotechnol; 2015 Jul; 99(14):5985-96. PubMed ID: 25794873
[TBL] [Abstract][Full Text] [Related]
38. Mass production of somatic embryos expressing Escherichia coli heat-labile enterotoxin B subunit in Siberian ginseng.
Kang TJ; Lee WS; Choi EG; Kim JW; Kim BG; Yang MS
J Biotechnol; 2006 Jan; 121(2):124-33. PubMed ID: 16174540
[TBL] [Abstract][Full Text] [Related]
39. Activation of Escherichia coli heat-labile enterotoxins by native and recombinant adenosine diphosphate-ribosylation factors, 20-kD guanine nucleotide-binding proteins.
Lee CM; Chang PP; Tsai SC; Adamik R; Price SR; Kunz BC; Moss J; Twiddy EM; Holmes RK
J Clin Invest; 1991 May; 87(5):1780-6. PubMed ID: 1902492
[TBL] [Abstract][Full Text] [Related]
40. Expression of Escherichia coli Heat-Labile Enterotoxin B Subunit in Centella (Centella asiatica (L.) Urban) via Biolistic Transformation.
Loc NH; Tung NV; Kim PTA; Yang MS
Curr Pharm Biotechnol; 2020; 21(10):973-979. PubMed ID: 32101119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
